Discussing Translation Of Pre-Clinical Models & The Role Of Biomarkers In Clinical Trial Design For Retinal Vascular Diseases
Time: 12:00 pm
day: Day Two
Details:
• Understanding the utility and limitations of pre-clinical models of retinal vascular disease
• Discussing the challenges of moving from pre-clinical into the clinic
• Role of biomarkers in evaluating proof of concept efficacy of therapeutics in early-stage trials
